Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
amy.lam@ndorms.ox.ac.uk

Research groups

Pharmaco- and Device epidemiology

Amy Lam

Postdoctoral Researcher in Real World Evidence

Recent publications

Effectiveness and waning of the fourth dose mRNA COVID-19 vaccines for the prevention of SARS-CoV2 infection related hospitalisations and deaths.

Li X. et al, (2026), J Infect

CohortSymmetry: An R package to perform sequence symmetry analysis using the OMOP common data model

Chen X. et al, (2025)

Reply to: Comments on "Long-term use of low-dose aspirin for cancer prevention: A 20-year longitudinal cohort study of 1,506,525 Hong Kong residents".

Lam A. and Tsoi K., (2025), Int J Cancer, 157

Long-term use of low-dose aspirin for cancer prevention: A 20-year longitudinal cohort study of 1,506,525 Hong Kong residents.

Lam A. et al, (2025), Int J Cancer, 156, 2330 - 2339

Prevalence, Behaviors, and Factors of Over-the-counter Aspirin Use in Hong Kong

Lam ASM. et al, (2025), Asian Journal of Social Health and Behavior, 8, 59 - 65

More publications